Sunshine Biopharma News

NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB

May 15 09:45

8-K: Current report

May 8 15:28

8-K: Current report

May 6 11:19

8-K: Current report

Apr 23 15:11

Sunshine Biopharma | 8-K: Current report

Apr 1 13:32

Sunshine Biopharma | DEF 14C: Definitive information statements

Mar 15 10:16

Sunshine Biopharma | 8-K: Current report

Mar 6 15:12

Sunshine Biopharma | DEF 14C: Definitive information statements

Mar 5 10:40

Sunshine Biopharma | 8-K: Current report

Mar 1 15:25

Sunshine Biopharma | 8-K: Current report

Feb 16 16:03

Sunshine Biopharma | 8-K: Current report

Feb 15 10:42

Sunshine Biopharma | 8-K: Current report

Feb 12 08:09

Sunshine Biopharma | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Feb 9 16:20

Sunshine Biopharma | S-1: General form for registration of securities under the Securities Act of 1933

Feb 1 15:24

Sunshine Biopharma | 8-K: Current report

Jan 30 11:43

Sunshine Biopharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Jan 7 23:00

Sunshine Biopharma | 8-K: Current report

Dec 7, 2023 15:59

Sunshine Biopharma | 8-K: SUNSHINE BIOPHARMA REPORTS 2023 THIRD QUARTER RESULTS: REVENUES UP SIGNIFICANTLY OVER LAST YEAR DUE TO A KEY ACQUISITION

Nov 13, 2023 08:00

Sunshine Biopharma | 8-K: Current report

Nov 2, 2023 11:18

Sunshine Biopharma | 8-K: Current report

Oct 20, 2023 12:06